Skip to content

Single Incision Laparoscopic Cholecystectomy

Single Incision Laparoscopic Cholecystectomy

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00678873
Acronym
SILC
Enrollment
20
Registered
2008-05-16
Start date
2008-03-31
Completion date
2009-12-31
Last updated
2009-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholelithiasis

Keywords

Single Incision, Single Access, Surgery, Cholecystectomy

Brief summary

The investigators aim to investigate the safety, feasibility and short-term outcomes of Single Incision Laparoscopic Cholecystectomy. The investigators hypothesize that Single Incision Laparoscopic Cholecystectomy is safe and feasible.

Detailed description

Laparoscopic cholecystectomy is the standard approach for the treatment of gallbladder disease. Laparoscopic cholecystectomy is now performed as an outpatient procedure and it commonly requires the use of 4 separate small incisions. Single incision or single access trans-umbilical surgery may provide less pain, scarring and may improve patient's overall satisfaction. In this phase I trial we aim to evaluate the safety, feasibility and short-term outcomes of Single Incision Laparoscopic Cholecystectomy for the treatment of symptomatic cholelithiasis (gallstones).

Interventions

A single trans-umbilical incision laparoscopic cholecystectomy will be performed by standard fashion and under general anesthesia.

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults male and female(\>18 years old) * Capable of giving informed consent * Ultrasound proven cholelithiasis * Symptomatic cholelithiasis * Elective cholecystectomy

Exclusion criteria

* Pregnancy * Contraindications for general anesthesia * Morbid obesity * Multiple previous abdominal surgeries * Uncontrolled medical conditions * Acute cholecystitis

Design outcomes

Primary

MeasureTime frame
Safety and feasibility12 months

Secondary

MeasureTime frame
Short-term clinical outcomes12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026